These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20635880)

  • 1. Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.
    Martorelli D; Muraro E; Merlo A; Turrini R; Rosato A; Dolcetti R
    Int Rev Immunol; 2010 Aug; 29(4):371-402. PubMed ID: 20635880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
    Merlo A; Turrini R; Bobisse S; Zamarchi R; Alaggio R; Dolcetti R; Mautner J; Zanovello P; Amadori A; Rosato A
    J Immunol; 2010 May; 184(10):5895-902. PubMed ID: 20385879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human T cell immune response to Epstein-Barr virus.
    Landais E; Saulquin X; Houssaint E
    Int J Dev Biol; 2005; 49(2-3):285-92. PubMed ID: 15906243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes in EBV-related diseases].
    Kuzushima K
    Rinsho Ketsueki; 2000 Jun; 41(6):487-90. PubMed ID: 10921347
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.
    Woodberry T; Suscovich TJ; Henry LM; Davis JK; Frahm N; Walker BD; Scadden DT; Wang F; Brander C
    J Infect Dis; 2005 Nov; 192(9):1513-24. PubMed ID: 16206065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
    Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
    Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
    Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
    J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
    Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant AAV-LMP-induced LMP specific cytotoxic response to autologous lymphoblastoid cell lines tranformed by Epstein-Barr virus].
    Zhao F; Liu H; Zhou L; Cai W; Du B; Ye S; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):247-51. PubMed ID: 15617340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma.
    Masmoudi A; Toumi N; Khanfir A; Kallel-Slimi L; Daoud J; Karray H; Frikha M
    Cancer Treat Rev; 2007 Oct; 33(6):499-505. PubMed ID: 17544585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with virus-specific cytotoxic T lymphocytes after organ transplantation.
    Lucas KG; Sun Q
    Pediatr Transplant; 2006 Mar; 10(2):142-4. PubMed ID: 16573596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation.
    Torre-Cisneros J; Román J; Torres A; Herrera C; Caston JJ; Rivero A; Mingot E; Rojas R; Martín C; Martínez F; Gómez P
    J Infect Dis; 2004 Nov; 190(9):1596-9. PubMed ID: 15478063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic CD4 T cells in viral hepatitis.
    Aslan N; Yurdaydin C; Wiegand J; Greten T; Ciner A; Meyer MF; Heiken H; Kuhlmann B; Kaiser T; Bozkaya H; Tillmann HL; Bozdayi AM; Manns MP; Wedemeyer H
    J Viral Hepat; 2006 Aug; 13(8):505-14. PubMed ID: 16901280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.